Jimmy Butts is the Chief Investment Strategist for Maximum Profit and Capital Wealth Letter, and a regular contributor to StreetAuthority Insider. Prior to joining StreetAuthority, Jimmy came from the financial services and banking industry where he worked as a Financial Advisor. There he specialized in providing customized retirement solutions for individuals. Jimmy graduated from Boise State University with a degree in business administration and finance. He also spent multiple years studying language, international business and finance in both Germany and Buenos Aires, Argentina. At one point he held his series 6, 63, 65 and 26 securities licenses. When he's not combing through financial statements or reading about finance, Jimmy enjoys being outdoors.

Analyst Articles

Shares of Fulgent Genetics (Nasdaq: FLGT) closed below our stop loss price of $87.82, yesterday, April 7. That means it’s time to cut our losses and move on from this trade. Unfortunately, things never got going with this stock and shares drifted lower from when I recommended it last month. Read More

The S&P 500 breached the 4,000 mark for the first time in history. Meanwhile, the Dow Jones Industrial Average is also hitting new highs and is the top-performing major index so far this year -- up 8.3%. That tops the S&P 500's performance of 7% and the Nasdaq 100's 3.4% year-to-date returns... Read More